Position in ROIV
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$2,621,868
+$2,276,865 QoQ
Shares Held
74,085
+494.8% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#183
of 494 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 15%
Shared 0%
None 85%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Inspire Investing, LLC holds $36,635,347 across 52 Biotechnology names. ROIV ranks #5 (7.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
79,780 | $4,473,264 | |
| 2 | EXEL |
Exelixis, Inc.
|
79,532 | $4,327,336 | |
| 3 | INCY |
Incyte Corp
|
33,749 | $3,825,786 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
15,859 | $3,821,543 | |
| 5 | ROIV |
Roivant Sciences Ltd.
This page
|
74,085 | $2,621,868 | |
| 6 | ZVRA |
Zevra Therapeutics, Inc.
|
173,016 | $2,481,049 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
8,616 | $1,613,604 | |
| 8 | INSM |
INSMED Inc
|
11,287 | $1,203,419 |
All Filings in ROIV
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,621,868 | 74,085 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $345,003 | 12,455 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $330,838 | 15,246 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $308,061 | 20,361 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $280,577 | 24,896 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $302,518 | 29,982 | Shares | Sole | 2025-06-03 | |
| No filing history on record for this holder in this stock. | ||||||